Astragaloside IV Overcomes Anlotinib Resistance in Non-small Cell Lung Cancer through miR-181a-3p/UPR-ERAD Axis
2024 · Current Computer - Aided Drug Design · 4 citations
https://doi.org/10.2174/0115734099252873231117072107
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
13
Papers
80
Citations
5
h-index
2
i10-index
Lihuai Wang is an academic researcher from First Affiliated Hospital of Hunan University of Traditional Chinese Medicine. The author has contributed to research in topics: Cancer-related molecular mechanisms research & RNA modifications and cancer & Endoplasmic Reticulum Stress and Disease. The author has an h-index of 5, co-authored 12 publications.
ORCID: 0009-0007-4635-3230Click to start Chat